The maker of Ozempic and Wegovy obesity drugs said some of the prices could come down, as President Trump called for drugmakers to immediately lower their prices for Medicaid. This comes as Novo ...

Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...

Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the ...

Health and Human Services Secretary Robert F. Kennedy Jr said that President Donald Trump calls him up “three or four times a week” to hound him with the same question. At such a critical moment in US ...

The Trump administration is launching a pressure campaign against prescription drugmakers in an effort to get them to lower ...

The results follow Novo’s worst weekly decline in its history after the company slashed its full-year guidance.

The shrinking ranks of "Dividend Knight" contenders. Healthcare stocks with hard times but high yields. What investors should ...

Medicare Advantage usage trends reveal slight declines in 2023, highlighting critical insights for policymakers amid rising ...

The Londonderry Township board of supervisors has postponed the decision on changing zoning rules to allow an AI data center ...

CMS often withholds coverage for reimbursement, disrupting the natural flow of the market and hindering access to proven ...

These tariffs would drastically undermine the price advantage Indian drug makers currently enjoy in the US, especially in ...